Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (391)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
470
8.510
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
79
3.640
 Why?
Immunologic Factors
13
2025
249
2.470
 Why?
Neurology
10
2018
112
2.240
 Why?
Immunosuppressive Agents
10
2024
855
1.560
 Why?
Neuromyelitis Optica
4
2023
139
1.100
 Why?
Natalizumab
11
2021
40
0.920
 Why?
Recurrence
8
2025
1111
0.870
 Why?
Diagnostic Errors
2
2017
178
0.690
 Why?
Brain
16
2025
2868
0.670
 Why?
Internship and Residency
5
2011
1240
0.630
 Why?
Drug Substitution
2
2019
60
0.630
 Why?
Fingolimod Hydrochloride
5
2020
43
0.620
 Why?
Rituximab
4
2020
205
0.590
 Why?
Data Collection
4
2011
662
0.580
 Why?
Dementia, Vascular
3
2009
20
0.570
 Why?
Medication Adherence
2
2019
513
0.530
 Why?
Early Medical Intervention
1
2017
60
0.520
 Why?
Early Diagnosis
2
2017
244
0.510
 Why?
Glatiramer Acetate
6
2019
18
0.490
 Why?
Magnetic Resonance Imaging
24
2025
3737
0.490
 Why?
Calcinosis
2
2009
238
0.480
 Why?
Humans
87
2025
141754
0.480
 Why?
Drug Monitoring
1
2019
399
0.460
 Why?
Physicians
4
2016
942
0.460
 Why?
Postural Balance
3
2018
238
0.440
 Why?
Antibodies, Monoclonal, Humanized
8
2023
913
0.410
 Why?
Fatigue
3
2018
339
0.380
 Why?
Dimethyl Fumarate
3
2020
12
0.360
 Why?
Immunoglobulin G
4
2023
900
0.350
 Why?
Middle Aged
39
2025
34647
0.320
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
28
0.320
 Why?
Practice Guidelines as Topic
1
2018
1570
0.320
 Why?
Withholding Treatment
2
2021
78
0.310
 Why?
Adult
43
2025
39391
0.300
 Why?
Psychiatry
2
2009
188
0.290
 Why?
Demyelinating Diseases
4
2019
85
0.280
 Why?
Cysts
1
2009
114
0.280
 Why?
HIV Long Terminal Repeat
3
2001
10
0.280
 Why?
Education, Medical
1
2011
271
0.270
 Why?
Autoantibodies
3
2023
1475
0.270
 Why?
Certification
1
2008
119
0.260
 Why?
Lymphopenia
2
2020
67
0.260
 Why?
Education
2
2007
109
0.260
 Why?
Central Nervous System Cysts
1
2006
13
0.260
 Why?
Female
49
2025
75943
0.260
 Why?
Clinical Trials as Topic
3
2016
1057
0.250
 Why?
Cerebral Arteries
1
2006
59
0.250
 Why?
Male
40
2025
70179
0.240
 Why?
Single-Blind Method
3
2023
289
0.240
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
53
0.240
 Why?
Cerebrovascular Disorders
1
2006
97
0.240
 Why?
DNA, Viral
2
1998
367
0.240
 Why?
Ethics, Medical
2
2015
85
0.230
 Why?
Societies, Medical
4
2019
859
0.230
 Why?
HIV Seropositivity
2
1998
127
0.230
 Why?
Treatment Outcome
12
2023
11181
0.220
 Why?
Drug Industry
2
2016
110
0.210
 Why?
Databases, Factual
3
2016
1448
0.210
 Why?
Double-Blind Method
4
2023
1989
0.210
 Why?
Conflict of Interest
2
2016
130
0.210
 Why?
AIDS Dementia Complex
3
2001
52
0.200
 Why?
Microglia
2
2024
255
0.200
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
68
0.190
 Why?
Heart Aneurysm
1
2002
12
0.190
 Why?
Quality of Health Care
2
2017
658
0.180
 Why?
B-Lymphocytes
5
2023
859
0.180
 Why?
Heart Septal Defects, Atrial
1
2002
60
0.180
 Why?
Interferon beta-1a
2
2019
13
0.180
 Why?
Lymphoma
2
2005
228
0.170
 Why?
Neuroimaging
1
2023
281
0.170
 Why?
Education, Medical, Continuing
2
2015
133
0.170
 Why?
Mental Disorders
2
2007
1130
0.170
 Why?
Central Nervous System Neoplasms
2
2005
169
0.170
 Why?
Agammaglobulinemia
1
2020
36
0.160
 Why?
Brain Neoplasms
4
2016
1305
0.160
 Why?
Interferon-gamma
1
2023
792
0.160
 Why?
Serum Sickness
1
2019
6
0.160
 Why?
Indans
1
2019
12
0.160
 Why?
Neutropenia
1
2020
157
0.160
 Why?
Oxadiazoles
1
2019
35
0.160
 Why?
Disease Progression
4
2021
2800
0.150
 Why?
Referral and Consultation
1
2005
799
0.150
 Why?
Diagnosis, Differential
4
2023
1502
0.150
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.140
 Why?
Adjuvants, Immunologic
3
2015
240
0.140
 Why?
Salvage Therapy
1
2019
154
0.140
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
258
0.140
 Why?
Herpesvirus 8, Human
1
1998
66
0.140
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.130
 Why?
Educational Measurement
3
2015
319
0.130
 Why?
Eye Movements
1
2018
88
0.130
 Why?
Central Nervous System
2
2005
265
0.130
 Why?
Physician-Patient Relations
2
2016
585
0.130
 Why?
Sarcoma, Kaposi
1
1998
80
0.130
 Why?
Patient Selection
2
2015
688
0.130
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
671
0.130
 Why?
Young Adult
7
2024
13749
0.130
 Why?
Herpesvirus 4, Human
1
2018
165
0.130
 Why?
Nervous System Diseases
2
2024
277
0.130
 Why?
Herpesviridae Infections
1
1998
148
0.130
 Why?
Suicide, Assisted
1
1997
26
0.130
 Why?
Neurologists
1
2016
22
0.130
 Why?
Costs and Cost Analysis
1
2017
222
0.120
 Why?
Estriol
1
2015
6
0.120
 Why?
Cost-Benefit Analysis
2
2016
619
0.120
 Why?
Aged
9
2024
24746
0.120
 Why?
Dizziness
2
2018
94
0.120
 Why?
Verbal Learning
2
2013
66
0.120
 Why?
Corpus Callosum
2
2006
70
0.120
 Why?
Retrospective Studies
10
2024
16374
0.110
 Why?
T-Lymphocytes
1
2023
2007
0.110
 Why?
Follow-Up Studies
6
2020
5212
0.110
 Why?
Trust
1
2016
147
0.110
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
156
0.110
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
60
0.100
 Why?
Medication Reconciliation
1
2013
31
0.100
 Why?
CD40 Antigens
1
2014
89
0.100
 Why?
Insurance, Health
1
2016
299
0.100
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
136
0.100
 Why?
Stroke
1
2002
1158
0.100
 Why?
JC Virus
1
2013
23
0.100
 Why?
Exercise Therapy
1
2018
454
0.100
 Why?
Anti-Inflammatory Agents
2
2006
482
0.100
 Why?
Sensation Disorders
1
2012
39
0.090
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
19
0.090
 Why?
Population Surveillance
1
2016
482
0.090
 Why?
Memory Disorders
1
2013
182
0.090
 Why?
Immunoglobulin Heavy Chains
3
2007
85
0.090
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.090
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
20
0.090
 Why?
HIV-1
2
2001
895
0.090
 Why?
Optic Nerve
2
2005
66
0.090
 Why?
T-Lymphocyte Subsets
1
2014
415
0.090
 Why?
Glioma
1
2016
427
0.090
 Why?
Gadolinium
4
2018
81
0.090
 Why?
United States
8
2024
15310
0.090
 Why?
Academies and Institutes
1
2011
55
0.080
 Why?
Self-Assessment
1
2011
76
0.080
 Why?
Learning
1
2015
439
0.080
 Why?
Nerve Regeneration
1
2010
59
0.080
 Why?
Fatal Outcome
3
2006
309
0.080
 Why?
Diagnostic Tests, Routine
1
2011
110
0.080
 Why?
Leukocytosis
1
2010
33
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
8
0.080
 Why?
Hemangioma, Cavernous
1
1989
14
0.080
 Why?
Antigens, CD19
3
2007
137
0.080
 Why?
Quality of Life
3
2021
3014
0.080
 Why?
Optic Chiasm
1
1989
18
0.080
 Why?
Biomarkers
3
2014
4190
0.080
 Why?
Central Nervous System Infections
1
2010
35
0.080
 Why?
Exercise Test
1
2012
624
0.080
 Why?
Severity of Illness Index
3
2014
2903
0.080
 Why?
Disease Management
1
2013
633
0.080
 Why?
Guidelines as Topic
1
2011
275
0.070
 Why?
Spinal Cord
3
2023
376
0.070
 Why?
Physical Therapy Modalities
1
2011
319
0.070
 Why?
Neuroprotective Agents
1
2009
142
0.070
 Why?
Hospital-Physician Relations
1
2007
3
0.070
 Why?
Immunoglobulin Variable Region
2
2004
81
0.070
 Why?
Practice Patterns, Physicians'
1
2016
1344
0.070
 Why?
Workload
1
2009
166
0.070
 Why?
Vasculitis, Central Nervous System
1
2006
15
0.060
 Why?
Neuropsychological Tests
2
2013
1093
0.060
 Why?
Headache Disorders
1
2006
19
0.060
 Why?
CD4-Positive T-Lymphocytes
1
1993
1115
0.060
 Why?
Nerve Fibers, Myelinated
1
2006
49
0.060
 Why?
Antibodies, Monoclonal
2
2011
1474
0.060
 Why?
Methylprednisolone
1
2006
64
0.060
 Why?
Medical Records
1
2007
182
0.060
 Why?
Syndrome
2
2023
378
0.060
 Why?
Glial Fibrillary Acidic Protein
1
2006
112
0.060
 Why?
International Classification of Diseases
1
2007
139
0.060
 Why?
Antibody Formation
1
2007
298
0.060
 Why?
Huntington Disease
1
2007
64
0.060
 Why?
Contrast Media
3
2018
470
0.060
 Why?
Intracranial Hemorrhages
1
2006
94
0.060
 Why?
Herpes Zoster
1
2010
319
0.060
 Why?
Adolescent
8
2024
22130
0.060
 Why?
Aquaporin 4
1
2006
102
0.060
 Why?
DNA Mutational Analysis
1
2006
398
0.060
 Why?
Canada
2
2019
429
0.060
 Why?
Health Care Surveys
1
2007
566
0.060
 Why?
Fellowships and Scholarships
1
2009
323
0.060
 Why?
Cognition Disorders
1
2009
518
0.060
 Why?
Analysis of Variance
3
2015
1321
0.060
 Why?
Neurologic Examination
1
2005
128
0.060
 Why?
RNA, Messenger
1
1992
2828
0.060
 Why?
Teaching
1
2007
237
0.060
 Why?
Patient Compliance
1
2009
611
0.050
 Why?
Surveys and Questionnaires
4
2016
5974
0.050
 Why?
Program Evaluation
1
2009
930
0.050
 Why?
Affect
1
2007
316
0.050
 Why?
Erythrocytes
1
2010
707
0.050
 Why?
Central Nervous System Diseases
1
2005
73
0.050
 Why?
Colorado
2
2024
4629
0.050
 Why?
Simvastatin
1
2004
63
0.050
 Why?
Neutrophils
1
2010
1282
0.050
 Why?
Ophthalmoplegia
1
2003
13
0.050
 Why?
Proteoglycans
1
2004
109
0.050
 Why?
Prevalence
2
2024
2799
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
50
0.050
 Why?
Faculty, Medical
1
2006
296
0.050
 Why?
B-Lymphocyte Subsets
1
2003
78
0.050
 Why?
Cyclophosphamide
1
2003
257
0.050
 Why?
Radiography
1
2005
844
0.050
 Why?
Neurodegenerative Diseases
1
2024
141
0.050
 Why?
Infusions, Intravenous
1
2023
417
0.050
 Why?
Patient Outcome Assessment
1
2023
131
0.050
 Why?
Academic Medical Centers
1
2005
531
0.050
 Why?
Anticoagulants
1
2006
675
0.040
 Why?
Membrane Glycoproteins
1
2004
502
0.040
 Why?
Students, Medical
1
2006
369
0.040
 Why?
Lymphoma, B-Cell
2
2005
131
0.040
 Why?
Induced Pluripotent Stem Cells
1
2024
265
0.040
 Why?
Single-Cell Analysis
1
2024
338
0.040
 Why?
Pain
1
2007
781
0.040
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
37
0.040
 Why?
Molecular Sequence Data
3
2004
2929
0.040
 Why?
Dementia
1
2005
263
0.040
 Why?
Disability Evaluation
2
2014
304
0.040
 Why?
Peptides
3
2013
979
0.040
 Why?
Cross-Sectional Studies
1
2012
5697
0.040
 Why?
Schools, Medical
1
2002
152
0.040
 Why?
Antibodies, Antinuclear
1
2001
66
0.040
 Why?
Time Factors
4
2018
6966
0.040
 Why?
Atrophy
1
2021
197
0.040
 Why?
Clinical Competence
1
2008
1205
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
161
0.040
 Why?
Mobility Limitation
1
2020
63
0.040
 Why?
Venous Thrombosis
1
2002
192
0.040
 Why?
Child
5
2016
22414
0.040
 Why?
Interferon-beta
2
2011
94
0.040
 Why?
Lymphocyte Activation
1
2003
1150
0.040
 Why?
Antibodies, Viral
1
2023
656
0.040
 Why?
Maintenance Chemotherapy
1
2019
38
0.040
 Why?
Cerebral Infarction
1
1998
50
0.040
 Why?
Induction Chemotherapy
1
2019
80
0.040
 Why?
Cell Separation
2
2014
317
0.040
 Why?
Lipids
1
2023
690
0.040
 Why?
HIV Seronegativity
1
1998
30
0.040
 Why?
Genes, myc
1
1998
48
0.030
 Why?
Base Sequence
2
2001
2180
0.030
 Why?
Transplantation, Autologous
1
2019
281
0.030
 Why?
Astrocytoma
1
1998
131
0.030
 Why?
In Situ Hybridization
1
2018
320
0.030
 Why?
Gene Library
1
1997
120
0.030
 Why?
Risk Assessment
1
2006
3508
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
346
0.030
 Why?
Gene Rearrangement
1
1998
151
0.030
 Why?
Syndecan-1
2
2007
41
0.030
 Why?
Managed Care Programs
1
1997
140
0.030
 Why?
Drug Administration Schedule
1
2018
771
0.030
 Why?
Breast Neoplasms
1
2008
2257
0.030
 Why?
Morals
1
1997
78
0.030
 Why?
Risk Factors
3
2008
10482
0.030
 Why?
Viral Load
1
2018
506
0.030
 Why?
Flow Cytometry
2
2014
1197
0.030
 Why?
Mutation
1
2006
4015
0.030
 Why?
Survival Analysis
1
2018
1320
0.030
 Why?
Polymerase Chain Reaction
1
1998
1056
0.030
 Why?
Sequence Analysis, DNA
1
1997
825
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1406
0.030
 Why?
Child, Preschool
3
2016
11512
0.030
 Why?
Incidence
1
2020
2806
0.030
 Why?
Patient Care Team
1
2019
673
0.030
 Why?
Congresses as Topic
1
2015
230
0.020
 Why?
Propylene Glycols
1
2013
28
0.020
 Why?
Ocular Physiological Phenomena
1
1992
10
0.020
 Why?
HLA-DR Antigens
1
2014
228
0.020
 Why?
Sphingosine
1
2013
45
0.020
 Why?
Quality-Adjusted Life Years
1
2013
113
0.020
 Why?
beta-Galactosidase
1
1992
78
0.020
 Why?
Markov Chains
1
2013
126
0.020
 Why?
Drug Therapy, Combination
1
2015
1041
0.020
 Why?
Mice, Inbred DBA
1
1992
200
0.020
 Why?
Leukocyte Count
1
1993
328
0.020
 Why?
Haplotypes
1
2014
499
0.020
 Why?
Organ Specificity
1
1992
312
0.020
 Why?
Reference Values
1
2013
807
0.020
 Why?
Comparative Effectiveness Research
1
2013
164
0.020
 Why?
Ki-67 Antigen
1
2012
111
0.020
 Why?
CD3 Complex
1
2012
106
0.020
 Why?
Mental Recall
1
2013
210
0.020
 Why?
Intestine, Small
1
1992
157
0.020
 Why?
Thymus Gland
1
1992
319
0.020
 Why?
Mitoxantrone
1
2011
14
0.020
 Why?
Mice
2
2023
18109
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Animals
3
2023
37749
0.020
 Why?
Muscle Stretching Exercises
1
2011
19
0.020
 Why?
Patient Participation
1
2015
432
0.020
 Why?
Clinical Laboratory Techniques
1
2011
96
0.020
 Why?
Depression
2
2011
1508
0.020
 Why?
Recombinant Fusion Proteins
1
1992
674
0.020
 Why?
Amino Acid Sequence
2
2004
2158
0.020
 Why?
Physical Endurance
1
2011
275
0.020
 Why?
Acyclovir
1
2010
95
0.020
 Why?
Spinal Cord Neoplasms
1
1989
41
0.020
 Why?
Cell Count
1
2010
326
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1634
0.020
 Why?
History, 19th Century
1
2009
61
0.020
 Why?
Respiratory Function Tests
1
2011
560
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
59
0.020
 Why?
Aged, 80 and over
2
2016
7923
0.020
 Why?
Injections
1
2009
191
0.020
 Why?
History, 21st Century
1
2009
220
0.020
 Why?
Autoimmunity
1
2014
908
0.020
 Why?
Pilot Projects
2
2004
1826
0.020
 Why?
Electrocardiography
1
2011
618
0.020
 Why?
History, 20th Century
1
2009
330
0.020
 Why?
Gene Expression
1
1992
1492
0.020
 Why?
Mice, Transgenic
1
1992
2184
0.020
 Why?
Age of Onset
1
2009
534
0.020
 Why?
Health
1
2007
84
0.020
 Why?
Memory
1
2009
263
0.020
 Why?
Association Learning
1
2007
63
0.020
 Why?
Walking
1
2011
548
0.020
 Why?
Herpesvirus 3, Human
1
2010
336
0.020
 Why?
Cerebral Ventricles
1
2006
55
0.020
 Why?
Prognosis
2
2006
4080
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
918
0.020
 Why?
Motor Skills
1
2007
103
0.010
 Why?
Hypothalamus
1
2006
155
0.010
 Why?
Genetics
1
2005
24
0.010
 Why?
Phenotype
1
2014
3177
0.010
 Why?
Models, Theoretical
1
2009
584
0.010
 Why?
Immunologic Memory
1
2007
360
0.010
 Why?
Neurosciences
1
2005
25
0.010
 Why?
Hospitalization
1
2015
2264
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Social Support
1
2009
633
0.010
 Why?
Clinical Protocols
1
2006
273
0.010
 Why?
Anisotropy
1
2004
79
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
278
0.010
 Why?
Internet
1
2009
690
0.010
 Why?
Immune System
1
2005
183
0.010
 Why?
Plasma Cells
1
2004
74
0.010
 Why?
Antiviral Agents
1
2010
747
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
12
0.010
 Why?
Infrared Rays
1
2003
26
0.010
 Why?
Meningitis, Viral
1
2003
20
0.010
 Why?
Videotape Recording
1
2003
39
0.010
 Why?
Antilymphocyte Serum
1
2003
59
0.010
 Why?
Saccades
1
2003
45
0.010
 Why?
Oligoclonal Bands
1
2003
20
0.010
 Why?
Antigens, CD34
1
2003
89
0.010
 Why?
Clone Cells
1
2003
267
0.010
 Why?
Whole-Body Irradiation
1
2003
78
0.010
 Why?
Astrocytes
1
2005
217
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
133
0.010
 Why?
Immunoglobulins
1
2003
168
0.010
 Why?
Observer Variation
1
2003
357
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
188
0.010
 Why?
Feasibility Studies
1
2006
1027
0.010
 Why?
Mice, Inbred C57BL
1
1992
5909
0.010
 Why?
Administration, Oral
1
2004
803
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
9
0.010
 Why?
Age Factors
1
2009
3294
0.010
 Why?
Consensus Sequence
1
2001
74
0.010
 Why?
Longitudinal Studies
1
2009
2938
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2765
0.010
 Why?
Cytomegalovirus Infections
1
2003
197
0.010
 Why?
Biopsy
1
2005
1083
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
987
0.010
 Why?
Sex Characteristics
1
2007
792
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
24
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
59
0.010
 Why?
Urinary Tract Infections
1
2003
194
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
99
0.010
 Why?
Infant
1
2015
9843
0.010
 Why?
Cohort Studies
1
2011
5815
0.010
 Why?
Predictive Value of Tests
1
2006
2075
0.010
 Why?
Acute Disease
1
2003
1010
0.010
 Why?
Combined Modality Therapy
1
2003
1249
0.010
 Why?
Research
1
2003
455
0.010
 Why?
Lung
1
1992
4137
0.010
 Why?
Arachnoid
1
1998
12
0.010
 Why?
Sensitivity and Specificity
1
2003
1977
0.010
 Why?
Survival Rate
1
2003
1972
0.010
 Why?
Monocytes
1
2001
579
0.010
 Why?
Virus Replication
1
2001
532
0.010
 Why?
Binding Sites
1
2001
1316
0.010
 Why?
Models, Biological
1
2005
1828
0.010
 Why?
Case-Control Studies
1
2004
3597
0.010
 Why?
Aging
1
2007
1924
0.010
 Why?
Reproducibility of Results
1
2003
3356
0.010
 Why?
Transcription, Genetic
1
2001
1487
0.010
 Why?
DNA-Binding Proteins
1
2001
1485
0.010
 Why?
Cells, Cultured
1
2001
4212
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (391) concept(s)
_
Co-Authors Expand Description
See all (39) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)